Colombo, Sri Lanka – The Ministry of Health announced on Tuesday that Dr. Ruwan Perera, the deputy director of the Colombo General Hospital, has been suspended pending a formal inquiry into alleged irregularities in the procurement of emergency medical supplies. The suspension follows a series of allegations that the hospital’s procurement unit bypassed standard bidding procedures while acquiring life‑saving drugs and equipment after the country’s worst monsoon‑season floods of the past decade.
“We take any allegation of misconduct very seriously, especially at a time when the health system is under unprecedented pressure,” the ministry’s spokesperson, Ananda Mahawalage, said in a statement released to local media. “The suspension is a precautionary measure to ensure the integrity of the ongoing investigation and to prevent any further risk to patient care.”
Background: A health system strained by crisis
The suspension comes amid a broader health‑sector crisis that has drawn international attention. In 2022, Sri Lanka defaulted on its sovereign debt, prompting a $2.9 billion program with the International Monetary Fund (IMF) that required the government to tighten fiscal policy while maintaining essential public services. The pandemic‑induced collapse of tourism, soaring oil prices, and a shortage of foreign exchange have since left hospitals scrambling for supplies.
According to a recent report by the World Health Organization, only 71 percent of essential medicines were available in state‑run hospitals as of June 2024, a figure that fell sharply after the floods that inundated large parts of the island in November 2025. The floods killed at least 1,300 people across Indonesia, Sri Lanka, and Thailand and left more than 1 million Sri Lankans displaced, overwhelming the nation’s emergency response capacity and exposing gaps in medical logistics.
“The health sector is a litmus test for Sri Lanka’s recovery,” said Dr. Lalitha Fernando, a public‑health analyst at the University of Colombo. “Any breach of procurement integrity risks not only lives but also the credibility of the IMF‑backed reform plan, which hinges on transparent use of limited resources.”
Alleged procurement breaches
Investigators allege that the deputy director authorized the purchase of high‑cost oncological drugs, including the monoclonal antibody bevacizumab, without the requisite competitive tender. The ministry claims the contracts were awarded to a local supplier linked to a political patronage network, raising concerns about potential kickbacks.
Hospital staff interviewed by the Associated Press reported that the procurement officers diverted funds meant for emergency response to purchase equipment that was later found unused or duplicate. “We were told to prioritize certain items, yet the supplies never arrived, and patients were left without critical care,” said senior nurse Anusha Jayarathna, who asked to remain anonymous for fear of retaliation.
The Ministry of Health has launched an internal audit, and the Comptroller and Auditor General’s office has been asked to conduct an independent review. If the allegations are substantiated, the deputy director could face charges under Sri Lanka’s Anti‑Corruption Act, which carries penalties of up to five years’ imprisonment.
International response and implications
The suspension has been noted by several international bodies monitoring Sri Lanka’s recovery. The IMF’s regional office in Bangkok reiterated its commitment to “support transparent governance” as a condition for continued disbursements. Reuters reported that the IMF could withhold tranche releases if governance lapses persist, potentially jeopardizing a $500 million balance‑of‑payments line earmarked for health‑sector stabilization.
Neighboring India, a key supplier of medical imports, issued a statement through its Ministry of External Affairs emphasizing “the importance of swift, transparent action to restore confidence in Sri Lanka’s health procurement processes,” underscoring the bilateral trade interdependence that has grown since the 2022 debt restructuring.
Beyond financial considerations, experts argue that the episode could affect regional stability. Sri Lanka’s strategic location along the Indian Ocean sea lanes makes its internal governance a matter of interest for both the United States and China, whose naval presences are expanding in the region. A weakened health system could exacerbate social unrest, potentially creating a vacuum that external powers might exploit.
Next steps for Sri Lanka’s health governance
Following the suspension, the Ministry of Health announced the formation of a “Special Procurement Review Committee” comprising senior civil servants, representatives from the Ministry of Finance, and independent auditors. The committee is tasked with delivering a report within 30 days, recommending corrective actions and possible legal proceedings.
In the meantime, the hospital has appointed an acting deputy director, Dr. Nalini Silva, who pledges to “restore normalcy and ensure that essential medicines reach the wards without delay.” The hospital’s procurement unit has also begun a rapid audit of all contracts signed in the past twelve months, with an emphasis on aligning purchases with the World Health Organization’s Essential Medicines List.
For a broader view of the nation’s flood response and its impact on health infrastructure, see Globally Pulse’s in‑depth coverage of the ongoing relief effort.
The suspension of Dr. Perera underscores the fragile intersection of health governance, economic recovery, and international oversight in Sri Lanka. As the country strives to meet IMF conditions and rebuild a health system battered by natural disaster and financial turmoil, transparent administration will be crucial to restoring both public trust and the flow of essential external assistance.
